About Ribbon

Ribbon is a part of the Fresenius Kabi group, specialized in cGMP manufacturing of the API beta-lactam antibiotics, both oral and sterile grades. With the latest state-of-the-art technologies, we supply pharmaceutical companies worldwide with a range of anti-infective products for human and veterinary use. Since the foundation of Ribbon in 1975, the company has continuously developed its presence in semi-synthetic penicillin and cephalosporin markets. Our portfolio is complemented with several new APIs every year as our strong commitment is to help our customers to launch first generics in their markets.

Having almost 40-years of experience in the field of beta-lactam APIs we offer to all our customers extensive technical, development and regulatory service supported by project management structure. Today we have two plants in Italy where we manufacture APIs and intermediates, one in Villadose (Rovigo), near Venice and another one in Taccona di Muggio, (Milan region). As our strong commitment is to support our current and future customers we continue to expand our production capacities. We operate in Europe, South America, North Africa, Asia (including Japan), Australia and USA based on long-term relationships with customers.

In December 2007 we became a part of the Fresenius Kabi Group (www.freseniuskabi.com), subsidiary of FRESENIUS SE, a global health care company with products and services for dialysis, the hospital and the medical care of patients at home. Fresenius Kabi is a leader in infusion therapy and clinical nutrition in Europe and in the growth regions of Asia-Pacific and Latin America, also among leading suppliers of IV generic products in the US market. Through the wide network Fresenius Kabi provides treatment and care for critically ill patients in both hospital and out-patient environments. Being a part of this pharmaceutical group has given us great opportunity to widen our geographical presence and broaden our expertise in the end-user market. On the operational side, it has also provided us with access to the latest production management techniques.